| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 652,681 | 497,049 | 285,351 | 46,330 |
| Accounts receivable and unbilled, net (includes 3.1 million and 3.5 million with related parties at march31, 2026 and december31, 2025, respectively) | 394,581 | 402,078 | 373,034 | 377,921 |
| Prepaid expenses and other current assets | 91,793 | 90,497 | 78,900 | 96,554 |
| Total current assets | 1,139,055 | 989,624 | 737,285 | 520,805 |
| Property and equipment, net | 136,548 | 131,055 | 133,175 | 135,481 |
| Operating lease right-of-use assets | 126,812 | 117,815 | 123,586 | 129,504 |
| Goodwill | 662,396 | 662,396 | 662,396 | 662,396 |
| Intangible assets, net | 33,265 | 33,420 | 33,657 | 33,893 |
| Deferred income taxes | 3,220 | 19,223 | 37,189 | 65,792 |
| Other assets | 28,317 | 21,939 | 25,724 | 23,802 |
| Total assets | 2,129,613 | 1,975,472 | 1,753,012 | 1,571,673 |
| Accounts payable (includes 0.2 million and 0.3 million with related parties at march31, 2026 and december31, 2025, respectively) | 34,429 | 28,142 | 26,523 | 43,275 |
| Accrued expenses | 406,059 | 408,382 | 368,746 | 323,505 |
| Advanced billings (includes 13.7 million and 12.3 million with related parties at march31, 2026 and december31, 2025, respectively) | 856,344 | 854,390 | 834,328 | 808,783 |
| Other current liabilities | 48,182 | 52,834 | 54,317 | 44,880 |
| Total current liabilities | 1,345,014 | 1,343,748 | 1,283,914 | 1,220,443 |
| Operating lease liabilities | 122,256 | 113,643 | 119,067 | 124,946 |
| Deferred income tax liability | 3,925 | 1,355 | 1,899 | 2,016 |
| Other long-term liabilities | 60,104 | 57,655 | 54,491 | 51,917 |
| Total liabilities | 1,531,299 | 1,516,401 | 1,459,371 | 1,399,322 |
| Common stock - 0.01 par-value 250,000,000 shares authorized at march31, 2026 and december31, 2025 28,559,689 and 28,370,780 shares issued and outstanding at march31, 2026 and december31, 2025, respectively | 286 | 284 | 282 | 281 |
| Treasury stock - 69,623 shares at march31, 2026 and december31, 2025 | 12,156 | 12,156 | 12,235 | 12,235 |
| Additional paid-in capital | 953,416 | 935,830 | 907,483 | 893,174 |
| Accumulated deficit | -336,111 | -459,981 | -596,237 | -703,215 |
| Accumulated other comprehensive loss | -7,121 | -4,906 | -5,652 | -5,654 |
| Total shareholders equity | 598,314 | 459,071 | 293,641 | 172,351 |
| Total liabilities and shareholders equity | 2,129,613 | 1,975,472 | 1,753,012 | 1,571,673 |
Medpace Holdings, Inc. (MEDP)
Medpace Holdings, Inc. (MEDP)